Research Paper on EZH2 Blockade Reversing Doxorubicin Resistance in Breast Cancer

A research paper from figshare authored by Xiaomin Wang, last updated in May 2026. The 28.7 KB document describes a study investigating the role of EZH2 in doxorubicin resistance in breast cancer, including in vitro and in vivo experiments with transcriptomic profiling.

Use Cases

• Literature review on EZH2's role in chemoresistance based on the described experimental findings.
• Analyzing the described transcriptomic pathway alterations to understand metabolic vulnerabilities in resistant cells.
• Studying the efficacy of pH-responsive liposomal drug delivery systems based on the in vivo results mentioned.

Strengths

• The document is openly licensed under CC-BY-4.0.
• The description provides a detailed summary of the study's background, methods, results, and conclusions.

Limitations

• The dataset is a 28.7 KB DOCX file, indicating a very limited scope likely containing only the research paper.
• Row count and column-level documentation are absent; the actual data content must be inspected after download.
• The description metadata is limited; it does not specify the underlying experimental data tables or sample counts.

Provenance

Source

figshare, author Xiaomin Wang.

Collection Method

Likely contains the written results of laboratory experiments and analyses as described.

Time Range

null

Freshness

Last updated 2026-05 07:17:41; freshness should be verified.

Geography

null